Perspective Therapeutics, Inc. — Director's Dealing 2024

Nov 26, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2024-11-25

Reporting Person: Spoor Johan M. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-25	Common Stock	P	14500	$3.784	Acquired	152072	Direct
2024-11-25	Common Stock	P	5400	$3.8	Acquired	5400	Indirect
2024-11-25	Common Stock	P	6600	$3.8	Acquired	66600	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10000	Indirect

Footnotes

F1: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.645 to $3.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transactions described in this footnote.